You are on page 1of 8

1.

Task
From: Journal of Economic Psychology <joep@elsevier.com>
Date: Wed, Jan 16, 2013 at 7:02 PM
Subject: Thank you for the review of JOEP-D-12-00434
To: <xxxx@columbia.edu>, <xxxx@gmail.com>

Ms. Ref. No.: JOEP-D-12-00434


Title: Separating gratitude from guilt in the laboratory
Journal of Economic Psychology

Dear Dr. Reuben,

Thank you for your review of this manuscript.

You may access your review comments and the decision letter (when available - you will be notified!) by
logging onto the Elsevier Editorial System at url: http://ees.elsevier.com/joep/. Please login as a Reviewer.

You can choose to start your 30 day access period at any time up to 6 months after the date you
accepted the invitation to review.

Kind regards,

GerlindeFellner
Associate Editor
Journal of Economic Psychology

review receipt? Y
(Y/N)

Journal: Journal of Economic Psychology

Date of review: 2013-1-16

Review Content:

Article title: Separating gratitude from guilt in the laboratory

Manuscript ID: JOEP-D-12-00434

Editor: GerlindeFellner

Editor Email:
2. Task
On 04/08/2014 15:36, "jlr@asbmb.org" <jlr@asbmb.org> wrote:

>MS ID#: JLR/2014/053215


>MS TITLE: MiR-125b regulates lipogenesis by targeting stearoyl-CoA
>desaturase-1 (SCD-1)
>
>
>Dear JLR reviewer:
>
>Thanks for reviewing the paper referenced above. A decision has been
>rendered. Should you wish to view the decision, please go to
>http://submit.jlr.org and enter your 'Reviewer Area' and click on the
>'Completed Reviews' queue.
>
>
>
>Best regards,
>
>Alan Attie
>Associate Editor
>
>Sent on: August 4, 2014
>

review receipt? Y
(Y/N)

Journal: Journal of Lipid Research

Date of review: 2014-8-4

Review Content:

Article title: MiR-125b regulates lipogenesis by targeting stearoyl-CoA


desaturase-1 (SCD-1)

Manuscript ID: JLR/2014/053215

Editor: Alan Attie

Editor Email:
3. Task
From: editorial@jove.com
To: xxx@hotmail.com
Date: Fri, 19 Oct 2012 03:35:42 -0400
Subject: Thank you for agreeing to review (JoVE50398)

Dear Dr.Tain,

Thank you for agreeing to review manuscript "5/6th nephrectomy to induce chronic kidney
disease in the rat" for the Journal of Visualized Experiments.

To download the paper now, please click this link: View Submission

You may submit your comments online at the JoVE submission site.

Instructions for reviewers can be found here.

Regards,

JoVE Peer Review


Journal of Visualized Experiments
617.945.9051 | peerreview@jove.com

reviewreceipt? N
(Y/N)

Journal:

Date of review:

Review Content:

Article title:

Manuscript ID:

Editor:

Editor Email:
4. Task
You-Lin Tain, MD, PhD
Associate Professor, Division of Pediatric Nephrology, Kaohsiung Chang Gung
Memorial Hospital
and Chang Gung University, College of Medicine, Kaohsiung, Taiwan
123 Dabi Road, Niausung, Kaohsiung 83301, Taiwan
E-mail address: xxxx@hotmail.com OR xxxx@adm.cgmh.org.tw
Office Tel: +886-7-7317123 ext. 8723
Tel: +886-975056995
Fax: +886-7-7338009> From: editorial@jbiomedsci.com
> To: xxxx@hotmail.com
> Subject: Review of Journal of Biomedical Science manuscript - Angiotensin-converting
enzyme ...
> Date: Wed, 12 Sep 2012 13:53:55 +0100
>
> Re: Tarek K Motawi Prof, Shohda A El-Maraghy Assis. prof and Mahmoud A Senousy
TA
> Angiotensin-converting enzyme inhibition and angiotensin AT1 receptor blockade
down-regulate angiotensin-converting enzyme expression and attenuate renal injury in
streptozotocin-induced diabetic rats
> Journal of Biomedical Science
>
>Dear Dr Tain,
>
> This is just a quick note to confirm receipt of your review of the above manuscript. In
case it is helpful, you will find a copy of your review at the end of this message. We will
be sending this to the authors as soon as we are able to come to a decision on the
manuscript. You will also find any confidential comments you sent to the editors below.
>
> Thank you for your assistance in reviewing the paper for Journal of Biomedical
Science.
>
> With best wishes,
>
>
> Julie Y.H. Chan
>The Journal of Biomedical Science Editorial Team
>
>e-mail: editorial@jbiomedsci.com
> Web: http://www.jbiomedsci.com/
>
>
> ***********
>
> Reviewer's report: Major Compulsory Revisions
> The authors investigated whether ACEI; enalapril and the ARB; valsartan have
beneficial effects on renal ACE mRNA and protein expression, serum ACE activity and
TGF-β1, and renal oxidative stress to protect the kidney against STZ-induced damage.
The authors concluded that: (1) ACEI and ARB suppress ACE expression; (2)
Hyperglycemia and oxidative stress contribute to ACE up-regulation; and (3) ACEI and
ARB protect the kidney against STZ-induced damage mainly by suppression of ACE
expression and Na+/K+-ATPase activity. There are a number of issues that need to be
addressed.
> 1.The protective role of ACEI/ARB on RAS and the pathophysiology of oxidative
stress/NO have been extensively studied both in STZ-induced and other diabetic animal
models. The present study has only corroborated or confirmed what is already known
and has not provided new or additional information.
> 2.The rat model cited [25] by the authors is totally different from the model used in this
study, including gender (F vs. M), doses of ACEI and ARB, and treatment course (30
days vs. 8 weeks). Any other reference?
> 3.The ACE mRNA expression shown in Fig 1A is determined by end-point RT-PCR
but not the qPCR method as the author described in the Method section.
>
>
> Level of interest: Reject as not of sufficient priority to merit publishing in this journal
>
> Quality of written English: Acceptable
>
> Statistical review: No, the manuscript does not need to be seen by a statistician.
>
>
>
> ***********
>
> Confidential comments to editors: Dear Editor,
> Most results are not novel. I suggest rejection for this manuscript in your journal. In
addition, I am wondering whether this is a resubmitted manuscript
(3798434567494451). There is no significant improvement compared to last version.
> Yours sincerely,
> You-Lin Tain, M.D. Ph.D.
>
>
> What next?: Reject as not of sufficient priority to merit publishing in this journal
>
> Declaration of competing interests: I declare that I have no competing interests.
review receipt? Y
(Y/N)

Journal: Journal of Biomedical Science


Date of review: 2012/9/12
Review Content: Reviewer's report: Major Compulsory Revisions
The authors investigated whether ACEI; enalapril and the ARB;
valsartan have beneficial effects on renal ACE mRNA and protein
expression, serum ACE activity and TGF-β1, and renal oxidative
stress to protect the kidney against STZ-induced damage. The
authors concluded that: (1) ACEI and ARB suppress ACE
expression; (2) Hyperglycemia and oxidative stress contribute to
ACE up-regulation; and (3) ACEI and ARB protect the kidney
against STZ-induced damage mainly by suppression of ACE
expression and Na+/K+-ATPase activity. There are a number of
issues that need to be addressed.
1.The protective role of ACEI/ARB on RAS and the
pathophysiology of oxidative stress/NO have been extensively
studied both in STZ-induced and other diabetic animal models.
The present study has only corroborated or confirmed what is
already known and has not provided new or additional information.
2.The rat model cited [25] by the authors is totally different from
the model used in this study, including gender (F vs. M), doses of
ACEI and ARB, and treatment course (30 days vs. 8 weeks). Any
other reference?
3.The ACE mRNA expression shown in Fig 1A is determined by
end-point RT-PCR but not the qPCR method as the author
described in the Method section.

Level of interest: Reject as not of sufficient priority to merit


publishing in this journal

Quality of written English: Acceptable

Statistical review: No, the manuscript does not need to be seen by


a statistician.

Article title: Angiotensin-converting enzyme inhibition and angiotensin AT1


receptor blockade down-regulate angiotensin-converting enzyme
expression and attenuate renal injury in streptozotocin-induced
diabetic rats
Manuscript ID:

Editor: Julie Y.H. Chan


Editor Email:

You might also like